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AIMS AND OBJECTIVES 
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1. To study the incidence and patterns of cervical nodal 
metastases in patients clinically presenting with T1 / 
T2, N0 squamous cell carcinoma of oral tongue. 
2. To study the various risk factors which predict the 
development of cervical nodal metastases. 
3. To compare the survival outcomes of observation and 
elective neck treatment.  
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MATERIALS AND 
METHODS 
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 A retrospective study of patients who presented with 
malignancies of the oral tongue treated in Cancer Institute 
(W.I.A) from 1995 to 2005 was done. There were 332 patients 
who presented with cT1/T2 N0 tongue cancers amongst 890 
patients who were treated for oral tongue cancers.  
 
Inclusion Criteria : 
 
• All patients with biopsy proven squamous cell carcinoma 
and who underwent their treatment in Cancer Institute. 
• Clinical T1 / T2 lesions with no palpable neck nodes 
 
Exclusion Criteria : 
 
• Patients with other histologies  
• Patients who had undergone treatment elsewhere and 
presented with recurrent T1 / T2 lesions  
 
 Pretreatment evaluation consisted of a thorough history 
and clinical evaluation of the primary site & regional lymph 
nodes, a biopsy confirmation of histology and Chest Xray for 
metastatic evaluation.  
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 The tongue primary was treated by brachytherapy in 288 
patients. External beam radiation was used in 32 patients and 
surgery was done for 12 patients. 
 
 Brachytherapy was given by afterloading technique from 
50 Gy to 70 Gy using Iridium192.  Teleradiation fields included 
the upper cervical nodes in addition to the primary. A total dose 
of 60 Gy was given in 32 – 34 #. Response of the primary and 
further management of residual or recurrent lesions was noted. 
 
 Patients were counselled about the options of neck 
treatment (observation vs elective neck dissection ). A decision 
was taken by the treating physician after discussion with the 
patient. 
  
 The occurrence of cervical adenopathy among those 
patients offered only observation was noted and further 
management of the cervical nodes was studied in detail 
including timing of the appearance of nodes, treatment given 
and the pathologic features of the resected specimen were 
studied.  Further recurrence patterns on followup was also 
noted. 
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 Followup of these patients was updated till 2010 or their 
death. Patients who had defaulted during treatment or refused 
further treatment were also noted.  
 
 Statistical analysis was done using Pearson’s chi-square 
test for univariate analysis and logistic regression analysis for 
multivariate analysis. Survival was calculated using life-tables 
analysis and various factors influencing survival were 
compared using Cox Regression analysis. 
 
 All statistical analysis was done using SPSS for Windows 
version 14. 
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BACKGROUND 
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 Squamous cell carcinoma of the oral cavity accounts for 
about 30% of all cancers in India1. It is the second most 
common cancer in India2. This high incidence is attributed to 
the widespread usage of tobacco, especially oral tobacco. There 
is a geographical variation among the distribution, with oral 
cavity cancers being more common in certain parts of India3.  
 
 The treatment requires a multimodal approach involving 
surgery and radiotherapy. Currently chemotherapy also is 
becoming an integral component of the treatment regimes. The 
single most important prognostic factor in oral cavity 
carcinoma is the presence of cervical lymph nodes. The 
occurrence of neck nodal metastases reduces the survival by    
50 % and the presence of extracapsular involvement reduces 
survival by another 50 %4.  
 
 Contemporary management incorporating advanced 
radiation techniques, better reconstructive facilities and modern 
chemotherapy and targeted therapeutic drugs have resulted in 
better locoregional control. As the main cause of treatment 
failure is locoregional, the better control rates achieved by the 
advances in treatment is likely to translate to better survival. 
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 WHO has classified the oral cavity into seven subsites and 
the oral tongue is one of them. Oral tongue carcinomas account 
for 35% - 40 % of all oral cavity cancers5. Due to the high 
incidence of nodal metastases, oral tongue carcinomas have a 
poorer prognosis compared to other subsites of the oral cavity6. 
About 30 % of tongue carcinomas present with palpable neck 
nodal metastases at the time of presentation7. 
 
 Early stage tongue carcinomas (T1 / T2, N0) account for 
35 % - 40 % of all tongue carcinomas7. In general, the local 
disease can be well controlled by a single therapeutic modality 
viz, either surgery or radiation alone. Due to high incidence of 
occult metastatic neck disease, the optimal management of the 
neck remains one of the most controversial areas in the field of 
head and neck oncology. 
 
 Despite the high incidence of these cancers in certain 
geographic areas, there have been very little evidence regarding 
the management of the neck. The options include observation 
or elective neck treatment. 
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REVIEW OF LITERATURE 
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 Early stage tongue cancers are treated by a single 
modality treatment, either surgery or definitive radiation. The 
local control rates for both the therapeutic modalities are 
similar. 
  
 Radiation can be used either in the form of external beam 
radiation or interstitial brachytherapy. In some very small 
lesions involving the tip of the tongue, intraoral cone can be 
used to deliver high radiation doses to a confined area.  
 
 The doses used for teletherapy usually ranges from 60 – 
65 Gy in 30 to 33 # .Doses used for brachytherapy range from 
50 – 70 Gy. The dose rate can be either in the low dose or high 
dose brachytherapy. Radiation source is usually in the form of 
afterloading catheters using Ir192. 
 
 Surgery consists of wide excision with margins of 1 cm 
from the tumor as detected by inspection or palpation. Based on 
the extent of defect created at the end of the resection, 
reconstruction involves many options ranging from simple 
primary closure to the use of microvascular free flaps. 
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 The choice of treatment for the primary depends on 
various factors including institutional policy, physician 
preference, patient preference, availability of radiation 
techniques and reconstruction facilities and the expected 
residual morbidity following the treatment modality. 
 
 Brachytherapy preserves maximal amount of normal 
tissue, however tissue effects in the long term due to fibrosis 
occur and include irradiation of adjacent normal tissue, leading 
to xerostomia, fibrosis, impaired tongue mobility and altered 
taste sensation. Due to the high doses of radiation, soft tissue 
necrosis and osteoradionecrosis are also seen as sequelae. 
 
 Of factors which influence the local control in 
brachytherapy are the dose rate, the gross appearance of the 
lesion an extension to posterior third of the tongue8,9. Older age 
(> 65 years) has been associated to higher incidence of delayed 
local recurrences10. 
 
 Complications of radiation including osteoradionecrosis   
(ORN) and severe mucositis have been reported to be around 
14 % and 17 % respectively8,9. 
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 Surgery causes altered phonation and difficulty in 
swallowing, in addition to the general risks associated with 
anesthesia and surgery. 
 
 The local disease control rates following surgery for early 
stage tongue cancers have been reported to be in the order of  
more than 75 %11.   
   
 The main advantage of surgery include the presence of the 
entire tumor specimen for pathological analysis which will 
consist ofgrade of the tumor, tumor status of margins, depth of 
infiltration, desmoplasia, muscular infiltration, perineural 
spread, lymphatic emboli and presence of associated dysplasia 
and insitu carcinoma which can aid in further treatment 
decisions. 
 
 In a direct comparison of local control rates between 
brachytherapy and surgery, surgery was found to be superior 
(95.4 % vs 84 % for T1 lesions and 93.8% vs 72.2 % for T2 
lesions)12.   
 
 However in institutes with more experience in 
brachytherapy, local control rates seem to be better. Local 
control for T1/T2 lesions have been reported to be 87% in a 
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series of 166 patients by Mazeron et al13 treated exclusively by 
brachytherapy. Even a smaller series of 19 patients 94% local 
control was reported by Leung et al14. 
 
 Low dose rate brachytherapy treatments have also 
reported to have 79% local control rates for T2 cancers15. As 
similar control rates can be achieved by either treatment 
modality16, either of them can be preferred for treatment of the 
primary. Most often the institutional treatment policies dictate 
the treatment modality of the primary.   
 
Cervical Nodal Metastases: 
 
 The most important prognostic factor in head and neck 
squamous cell carcinomas is the presence of neck nodal 
metastases17-19. 
 
 Hence if comparable local control rates are achieved for 
the primary disease, the next main focus of treatment should be 
aimed to achieve good regional nodal disease control. This 
guarantees the maximal chance of cure and offers the chance 
for the best treatment outcomes.  
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 The optimal management of clinically N0 neck has been 
very controversial. Among higher stage primaries (T3 / T4), the 
uniform recommendations have been to perform elective nodal 
metastases. In early stage cancers, the issue is controversial. 
The main reasons cited for this include the morbidity of neck 
dissection in the form of shoulder dysfunction, the cosmetic 
deformity and the small chance of mortality due to 
complications associated with the surgery. 
 
 The next controversial issue is with regards to the timing 
of neck surgery. There have been various arguments put forth 
for and against to elective neck treatment which will be 
subsequently elaborated. Weiss et al20 based on their decision 
analysis model recommend elective treatment for the neck 
when the risk of occult disease is more than 20%. This has been 
arrived on basis of analysis of the risk versus benefit ratio, 
taking into account the survival gains, the morbidity of 
treatment and has been generally well accepted. 
 
 If the fact that the “high-risk” group needs to be treated at 
an early stage is accepted, it brings forth the next question of 
what is the best therapeutic modality to address the neck.  
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 Mendenhall et al21 have analyzed the various subsets of 
head and neck cancers and have classified them into various 
risk groups based on the incidence of occult neck nodal 
metastases. 
 
  
 
Definition of Risk Groups for the Clinically N0 Neck 
 
Group 
Estimated Risk of 
Subclinical Neck
Disease Stage Site 
I low risk <20% T1 Floor of mouth, oral tongue, retromolar 
trigone,  gingiva, hard palate, buccal 
mucosa 
II intermediate
risk 
20% to 30% T1 Soft palate, pharyngeal wall, 
supraglottic larynx, Tonsil 
T2 Floor of mouth, oral tongue, retromolar 
trigone, gingiva, hard palate, buccal 
mucosa 
 
III high risk >30% T1-
T4 
Nasopharynx, pyriform sinus, base of 
tongue 
T2-
T4 
Soft palate, pharyngeal wall, 
supraglottic larynx, Tonsil 
T3-
T4 
Floor of mouth, oral tongue, retromolar 
trigone, gingiva, hard palate, buccal 
mucosa 
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 The recommendations are to address the neck when there 
is more than 20% incidence of occult nodal metastases. 
 
 It will be seen that T1 & T2 cancers of the oral tongue 
come under the low and intermediate risk groups. Hence there 
may be some reluctance in aggressive early surgical 
management as upto 70% of patients will be subjected to 
unnecessary surgery with associated morbidity. 
 
 But as the oral tongue and floor of mouth have been 
considered to behave more aggressively than other oral cavity 
subsites, there are proponents for more aggressive treatment for 
these cancers. 
 
 The rationale for elective neck treatment is on the 
following basis. It is known that there is a definitive incidence 
of occult nodal metastases in the clinically negative neck.  
Rationale of elective neck treatment is to address these necks 
early in the course of the disease to achieve best therapeutic 
benefit. 
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 If the neck is observed, these occult nodal metastases 
enlarge so as to become clinically evident at a later date. In 
addition, they also demonstrate extracapsular infiltration and 
spread to other nodes and other distant sites, thereby lessening 
the chances of cure. 
 
 The incidence of occult nodal metastases in T1/T2 tongue 
cancers during elective neck dissection of cN0 necks have been 
reported variably from 14% to 61%22,23. The incidence of neck 
failures in similar patients have been reported from 14% to 
49%22,24. 
  As the rates of occult metastases and recurrences are 
similar, it would be appealing to identify the necks containing 
occult disease and address them earlier.  
 
 Many factors and scoring systems have been studied in 
detail to predict the risks of occult micrometastases in the 
cervical nodes. Some of the well studied and reported factors 
are discussed below. 
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1) Tumor Size : 
 
 In general, higher T stages are associated with higher 
incidence of neck nodal metastases. Tytor et al25 report the 
incidence rates of 14% and 37% for T1 & T2 tumors 
respectively. However, not all authors find similar correlation. 
Rasgon et al and Byers et al did not find any such association 
in their series26,27. 
 
2) Perineural invasion and Lymphatic invasion : 
 
 Brown et al 28 report 71% vs 30% occult disease in the 
presence and absence of perineural invasion. Lydiatt et al29 in 
their study found perineural invasion to correlate with poorer 
local control as well. 
 
 Brown et al 28 report angiolymphatic invasion also as a 
predictor of occult metastases with 85% of neck nodal disease 
in its presence as opposed to 38% in its absence. 
 
3) DNA Ploidy : 
 
 Tytor et al reports 54% occurrence of metastases 
compared to 19% in the presence of DNA aneuploidy25.Another 
study reports aneuploidy as a poor prognostic factor and 
recommends using it as a factor to decide on management of 
the neck30. 
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4) Tumor growth pattern : 
 
 Tumors with an infiltrating or ulcerated pattern on gross 
appearance harbour neck metastases in 48% and 39% according 
to Yamazaki et al31. The same authors also report 31% and 19% 
incidence of neck disease in tumors displaying a superficial or 
exophytic growth pattern respectively. Similar relation has been 
reported in another study also32. 
 
 The presence of muscular infiltration and desmoplastic 
reaction also was a predictor of higher incidence of neck 
disease24. 
 
5) Tumor thickness :  
 
 This is a widely studied parameter and thicker lesions 
have been found to fare poorly as compared to thinner lesions.  
• Fukano33 et al :   5.9 % for  upto 5mm ; 64.7% for > 5 
mm. 
• Brown28 et al : 38% for upto 3 mm , 41% for 3 – 7 mm & 
55% for > 7 mm. 
• Kligerman34 et al : 7% for upto 4 mm & 30% for > 4 mm. 
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 In a series of 173 patients treated by brachytherapy, 
thickness of more than 8 mm had a higher incidence of nodal 
metastases35. Similarly another series of patients treated by 
brachytherapy found rates of 30%, 40% & 50% incidence for 
thickness of upto 5 mm, 5-10 mm and more than 10 mm36. On 
comparing various tumor thickness, O’Brien et al37 found a 
cutoff of 4 mm to be of discriminative value. Also Fakih et al38  
from Tata Memorial Hospital recommend a cutoff of 4 mm 
tumor thickness to address the neck electively. 
 
 Other lesser studied but reported factors include 
expression of Laminin-5 & MMTP-1 by tumor cells 39, 
consistency of the tumor40 and currently, genomic profiling41. 
 
 Due to lack of a single discriminating predictive factor, 
systems to predict the occult disease risk using multiple factors 
are also available. 
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 Sparano42 et al proposed a multivariate system 
incorporating the following factors : 
 
• Greater Tumor thickness 
• Greater muscle invasion 
• T2 stage 
• Poorly differentiated histology 
• Infiltrating type of growth pattern 
• Lymphatic invasion. 
 
 Scoring systems incorporating histologic factors have also 
been devised to predict the risk and to aid in management. 
Some of them are: 
 
1) Broder’s Score43: Classifies tumors into various grades 
based on differentiation and keratinization. Not found to be 
very predictive in many later day studies. 
 
2) Anneroth Score44: Grades the following on a scale of 1 
to 4 to give a final score as follows. 
 Parameters : 
 Keratinization 
 Polymorphism 
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 Mitoses 
 Inflammatory infiltration of invasive margin 
 Mode of invasion at the margin. 
 
Grade I   : 5 – 10 points 
Grade II  : 11 – 15 points 
Grade III : 16 – 20 points 
 
3) Bryne Score45: Mitoses is excluded from the Anneroth 
score and scores are till 16 only. 
 
4) Martinez – Gimeno Score46: Seven parameters are used 
to assign a risk score. They are  
 
 T stage 
 Intravascular invasion 
 Tumor grade 
 Tumor thickness 
 Tumor – Host Interface 
 Inflammatory infiltrate 
 Perineural spread 
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Treatment of Neck 
 
The options for management of the N0 neck include: 
• Observation  
• Elective Neck Treatment 
 Elective Neck Irradiation 
 Elective Neck Dissection 
 
Neck Evaluation 
 
 The aim of evaluation is to identify patients with occult 
disease and initiate treatment for them at an earlier date. This 
has been advocated because of the limitations of clinical 
examination alone in identifying small nodal metastases. 
 
1) Ultrasound Neck: Giancarlo et al47 when comparing 
ultrasound with palpation found no added advantage to usage of 
ultrasound. 
 
2) CT Scan : CT scan is routinely performed in the 
evaluation of head and neck cancers, also it is done for planning 
radiation. If the neck is imaged at the same time, nodes small 
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enough to be palpable can be picked up. Features suggestive of 
metastatic involvement include loss of fatty hilum, 
inhomogeneity, necrotic centre & perinodal stranding. Meritt et 
al48 report a sensitivity of 83% for CT scan in evaluation of the 
neck. 
 
3) PET – CT : A study revealed sensitivity rates of 70% and 
specificity of 82%49. 
 
4) Sentinel Node Biopsy : Based on initial experience from 
Breast cancer & melanoma, the role of sentinel node biopsy in 
head & neck cancers is fast emerging. Many authors have 
published their experiences with this modality. A recently 
published multi-institutional study reports a negative predictive 
value of 96% for this modality50. 
  
 The lack of experience and the restricted availability may 
preclude widespread usage of this investigation. The 
disadvantages of sentinel node biopsy in head & neck cancers 
are that since radiation therapy is an integral part of treatment 
of these cancers, the normal lymphatic pathways are altered and 
errors may occur. 
 
 However, in general all of these modalities may not offer 
much advantage over clinical examination. 
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Observation 
 
 This is based on the fact that many N0 necks never go on 
to develop recurrence and elective treatment of the neck results 
in unnecessary treatment of this group of patients.  
 
Justifications for this modality include: 
 
• Avoids overtreatment of the neck in patients who have 
no occult nodal metastases. 
• Reduces morbidity associated with surgery / radiation 
to the neck. 
• Careful clinical followup will identify patients who 
will fail in the neck at an early date and they can be 
addressed. 
• There is no detriment in survival if the neck nodes 
appear at a later date and neck is addressed at that time. 
 
 The criticism against this would include that as of yet, 
there is no reliable technique of identifying occult metastases 
and delays in treatment will be detrimental to outcome. Also is 
the fact that if patients are not compliant with their followup 
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schedule, the neck disease can become non-salvagable. Further 
argument would include that patients with clinically evident 
nodes necessarily undergo a radical neck dissection with its 
associated morbidity.   
 
Elective Neck Irradiation 
   
 This is recommended when the primary is treated by 
radiation. The neck is electively radiated till 50Gy to take care 
of occult metastatic disease.  
 
 The rates of control of occult metastatic disease has been 
reported to be as high as 99% using doses of 50 Gy51. 
Mendenhall when comparing elective neck radiation against 
observation reported failure rates of 1.9% vs 18%52. 
 
 Spaulding reports 95% neck control rates for elective neck 
radiation, compared to 38% for observation for T1N0 disease53. 
Hence the rates of neck failures can be extrapolated to 5% 
which compares against rates of 4% to 7% in patients 
undergoing elective neck dissection. 
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 However there are very few studies which directly 
compare observation against elective neck radiation. A small 
series of 73 patients support the use of elective neck radiation54. 
Another small study from Riyadh reports better neck control 
rates for neck dissection against neck radiation55. 
 
 The data on elective neck radiation has been inferential 
only as most of the studies are all of small numbers and have 
not been directly compared against other modalities.  
 
 The disadvantage of neck radiation is that due the post 
radiation effects, further followup of the neck is difficult. Also 
these patients are at risk of developing new head & neck 
malignancies. If the neck has already been radiated, the 
lymphatic pathways will be altered making treatment difficult 
in this setting.   
 
Elective Neck Dissection 
  
 Of all therapeutic modalities, elective neck dissection 
remains the standard against which others have been compared. 
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 This is due to the amount of pathologic information 
gained by surgery. This helps to identify necks at high risk of 
treatment failure and also adverse prognostic factors can be 
identified aiding adjuvant treatment choices. 
 
 Lindberg et al 56 based on the patterns of lymphatic 
drainage have established the various levels of nodal 
involvement in different subsites of the head & neck. Based on 
this seminal analysis, the concept of selective neck dissection, 
i.e., removal of the nodal stations likely to be involved by 
metastases has been proposed. 
 
 For oral cavity cancers, levels I to III have been found to 
be the primary drainage basin and selective neck dissection in 
the form of Supraomohyoid neck dissection (SOHND) has been 
advocated. Byers et al 30 have reported 16% incidence of skip 
metastasis to level III or IV lymphnodes and this has led people 
to advise extended SOHND to include level IV dissection also 
for oral tongue cancers.  
 
 However recent reports have suggested a much lower 
frequency of skip metastasis and advocate removal of level IV 
nodes only if level II or III nodes appear suspicious.  
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 The following advantages have been cited for elective 
neck dissection : 
 
• High incidence of occult metastases to the neck. 
• If limited neck dissection is done and done by 
experienced surgeons, morbidity is very minimal. 
• If the neck has to be exposed during surgery for the 
primary, neck dissection can be combined at the same 
time. 
• It may be very difficult to offer the follow up necessary to 
identify the conversion of a N0 to N+ neck. 
• Time delay associated in waiting for the N0 neck to 
become N+ will lead to regional and distant progression 
of the disease. 
• Cure rates have been found to be decreased in the 
presence of multiple nodes or enlarged nodes. 
• If the follow up protocol is not strictly adhered to, the 
neck node may become large enough and become 
unsalvageable. 
• Information obtained by pathologic analysis of neck 
dissection specimen will identify high risk patients and 
help in further prognostication and incorporation of 
adjuvant treatment. 
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 The role of neck dissection as both a staging and 
therapeutic manoeuvre is appreciated by the finding of adverse 
features on pathologic analysis. The most important features to 
be noted are the number of nodes involved, the levels of nodes 
involved, the presence of lymphovascular invasion and 
presence of extracapsular spread. 
 
 The presence of perinodal spread as already seen has been 
considered to be a very important prognosticator of recurrences. 
The size of the node has a bearing upon the incidence of 
perinodal spread, with nodes of 1 cm displaying evidence of 
perinodal spread in 20%, 2 cm nodes showing 50% and 3 cm or 
more nodes showing 70% chance of perinodal spread.   
 
 Myers et al57 report decreased survival in this group, with 
5 year overall survival of 73% for the pN0 group compared to 
43% for pN+ group. In a subgroup analysis, they also found 
that pN+/ECS-ve group had 51% survival vs 29% for 
pN+/ECS+ve group at 5 years. Presence of extracapsular spread 
was also found to significantly increase rates of neck recurrence 
and distant metastases. 
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 Another factor deserving special emphasis is the disparity 
between clinical and pathological involvement of neck nodes. 
The rates of occult metastatic disease was noted in 34% of 
necks58. 13% and 19% of cN0 necks had pN2 disease and 
perinodal spread on pathologic evaluation. 
 
 Also it was noted that there was 21% stage migration for 
T1 lesions and 26% for T2 lesions. The upstaging would have 
implications for further adjuvant treatment and prognosis. 
 
 Adjuvant radiation is indicated to the neck if more than 1 
node shows metastases, node size is more than 3 cm, there is 
evidence of perinodal spread, perineural spread, lymphatic 
emboli, soft tissue deposits in the neck or multilevel nodal 
involvement or if there has been unplanned surgical biopsy of 
the neck node. 
 
 The most contested issue in the treatment of the neck is 
the timing of neck dissection, i.e, the role of elective versus 
therapeutic neck dissection on first sign of appearance of neck 
nodes clinically. 
 
 Arguments put forth for therapeutic neck dissection are 
that survival in that population is not severely compromised. So 
far, there have been few studies which directly compare the two 
modalities. 
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1. Vandenbrouck et al59: On a group of 75 patients, he found 
survival rates of 49% for elective neck dissection versus 
47% for delayed neck dissection. 
 
2. Fakih et al38: Noticed better disease free & overall 
survival in patients undergoing elective neck dissection, 
cite that when thickness of invasion is more that 4 mm, 
elective neck treatment is warranted. 
 
3. Kligerman et al34: Noticed 72% survival against 49% 
survival for therapeutic versus elective neck dissection. 
 
4. Anthony Yuen et al60: No difference in survival was seen. 
 
 Most of the series have used surgery as the primary 
treatment modality for the primary. Even series which use 
radiation for the primary report better survival rates amongst 
patients undergoing elective neck dissection.  
 
 In a group of 233 patients61 elective neck dissection was 
found to have better outcomes than therapeutic neck dissection. 
Haddadin et al62 also report better survival for patients 
undergoing elective neck dissection.  
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 However, the issue of timing of neck dissection has never 
been really settled. Anil D’Cruz et al63 recently reporting their 
analysis on a group of 349 patients found that there was 
insufficient evidence to conclude that one treatment was better 
that the other. 
     
Contralateral Neck Nodes 
 
 The incidence of contralateral neck nodal metastases has 
been reported to be in the range of 4% to 6%64,65. Risk factors 
noted have included lesions involving tip of the tongue, lesions 
crossing the midline, previous neck radiation or neck 
dissection. The incidence is very low to warrant elective 
treatment for the same. 
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RESULTS 
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PATIENT CHARACTERISTICS 
 
STAGE 
T1 : 184 ( 55.4 %) 
 
T2 : 148 ( 44.6 %) 
 
MEDIAN AGE ( RANGE ) 
 
54 years ( 24 – 84 years ) 
MEDIAN SIZE ( RANGE ) 2 c.m ( 0.5 – 4 c.m ) 
COMORBID CONDITIONS
PRESENT : 105 ( 31.6 % ) 
 
NONE : 227 ( 68.4 % ) 
GRADE 
I : 91 ( 27.4 % ) 
II : 196 ( 59 % ) 
III : 45 ( 13.6 % ) 
GROWTH PATTERN 
INFILTRATING : 207( 62.3 % )
EXOPHYTIC : 78 ( 23.5 % ) 
ULCERATED : 47 ( 14.2 % ) 
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       Infiltrating     Exophytic         Ulcerated 
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MULTIVARIATE ANALYSIS OF RISK FACTORS 
PREDICTING NECK NODE METASTASES 
 
RISK FACTOR HAZARD 
RATIO 
95% 
CONFIDENCE 
INTERVALS 
p - 
VALUE 
AGE GROUP 
More than 40 years  
Upto 40 years 
 
1 
1.527 
 
 
0.660 – 3.531 
 
 
0.327 
GENDER 
Female 
Male 
 
1 
1.710 
 
 
0.802 – 3.647 
 
 
0.165 
SITE OF LESION 
Other Sites 
Lateral Border 
 
1 
2.634 
 
 
0.793 – 8.750 
 
 
0.114 
TREATMENT 
TYPE 
Brachytherapy 
Others 
 
 
2.128 
1 
 
 
0.883 – 5.125 
 
 
0.092 
GRADE OF 
TUMOR 
Grade 1 & 2 
Grade 3 
 
 
0.607 
1 
 
 
0.223 – 1.651 
 
 
1.651 
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RISK FACTOR HAZARD 
RATIO 
95% 
CONFIDENCE 
INTERVALS 
p - 
VALUE 
STAGE  
T1 
T2 
 
0.348 
1 
 
0.179 – 0.677 
 
0.002 
GROWTH 
PATTERN 
Non-Infiltrating 
Infiltrating 
 
 
0.483 
1 
 
 
0.660 – 3.531 
 
 
0.031 
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TREATMENT GROUPS AND OUTCOMES 
 
OBSERVATION ARM ( n = 236 ) 
 
No clinical neck failures   : 108 ( 45.8 % ) 
Clinically detected neck failures  : 128 ( 54.2 % ) 
Pathologically proven metastases  : 101 ( 42.8 % ) 
 
Neck Salvagability 
  Salvagable    : 98 ( 76.5 % ) 
  Non – salvagable  : 9 ( 7 % ) 
  Salvagable , but defaulted : 21 ( 16.5 % ) 
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Treatment of Neck 
 
 Neck dissection only   : 43 ( 33.6 % ) 
 Neck dissection + Radiation : 48 ( 37.5 % ) 
 Radiation only    : 14 ( 10.9 % ) 
 Palliative / No Treatment  : 23 ( 17.9 % ) 
 
Failure Patterns 
 
 Ipsilateral Neck recurrences  : 25 (19.5 %) 
 Contralateral Neck recurrences  : 10 ( 7.8 % ) 
 Distant Metastases    : 9 ( 3.8 % ) 
 New Primary    : 6 ( 2.5 % ) 
 
Histopathologic Features  
 
 Pathological Involvement  : 64 (70.3 %) 
 Multiple Nodal Involvement : 29 (31.9 %) 
 Perinodal Spread   : 50 (54.9 % ) 
 
Status At Last Followup 
 
 Alive, No disease   : 124 ( 52.5 % ) 
 Dead      : 89 ( 37.7 % ) 
 Lost to followup    : 23 ( 19.7 % ) 
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ELECTIVE TREATMENT ARM ( n = 96 ) 
 
Treatment of Neck 
 
 Neck dissection     : 64 ( 66.6 % ) 
 Radiation only    : 32 ( 33.3 % ) 
 
Failure Patterns 
 
 Ipsilateral neck recurrence  : 4 ( 4.2 % ) 
 Contralateral neck recurrence : 5 ( 5.2 % ) 
 Distant Metastases   : 4 ( 4.1 % ) 
 New primary     : 5 ( 5.2 % ) 
 
Histopathologic Features 
 
  Pathologic involvement  : 13 (20.3 %) 
  Multiple Nodal Involvement : 7 ( 10.8 % ) 
  Perinodal Spread   : 8 ( 12.5% ) 
 
Status At Last Followup 
 
  Alive, No disease    : 63 ( 65.6 % ) 
  Alive, With disease   : 3 ( 3.1 % ) 
  Dead      : 25 ( 26 % ) 
  Lost to followup    : 5 ( 5.2 % ) 
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CERVICAL NODAL METASTASES 
 
Elective Neck Dissection, n = 64 
 
 
Node Positive 13 ( 20.3 % ) 
Node Negative 51 ( 79.7 % ) 
Multiple Node Involvement 5 ( 7.8 % ) 
Perinodal Spread 8 ( 12.5 % ) 
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COMPARISON OF TREATMENT GROUPS 
 
 Observation 
Elective 
neck 
dissection 
Elective neck 
radiation 
Number 236 64 32 
5 yr OS 64% 86% 69% 
5 yr DFS 62% 77% 70% 
Ipsilateral neck 
recurrence 
101 ( 42.8%) 2(3.1%) 2(6.2%) 
Contralateral 
neck recurrence 
10(4.2 %) 4(6.2%) 1(3.1%) 
Distant 
metastases 
9 (3.8%) 3(4.7%) 1(3.1%) 
New primary 6(2.5%) 2 (3.1 %) 3(9.4%) 
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OBSERVATION  
ELECTIVE NECK 
DISSECTION 
 
OBSERVATION  
ELECTIVE NECK 
DISSECTION 
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OBSERVATION  
ELECTIVE NECK 
DISSECTION 
OBSERVATION  
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OCCULT METASTASES AND CLINICAL 
RECURRENCES  
 
 Occult nodal metastases are metastases which are not 
clinically evident and they can be detected only after pathologic 
examination of the neck dissection specimen. The various 
incidence rates reported in literature are: 
 
SERIES T - STAGE INCIDENCE 
(NUMBER) 
Kowalski24 T1 / T2 23.1 % ( n = 117) 
C.J.O’Brien66 T1 / T2 30 % ( n = 83 ) 
S.Akthar67 T1 / T2 32 % ( n = 94 ) 
Decroix Y68 T1 / T2 34 % ( n = 244 ) 
Yuen AP69 T1 / T2 36 % ( n = 50 ) 
Soo-youn An70 T1 / T2 15.4 % / 42.9 % ( n = 63 ) 
Bourgier C13 T2 44.6 % ( n = 279 ) 
Vandenbrouck 59 T1 / T2 49 % ( n = 36 ) 
 Jang22 T1 / T2 61 % / 69 % ( n = 69 ) 
Present T1 / T2 20.5 % / 20 % ( n = 64 ) 
52 
 
 The incidence of neck nodal recurrences reported for 
patients offered only observation in various series are: 
 
SERIES T - STAGE INCIDENCE 
(NUMBER) 
Kurokawa 23 T1 / T2 14 % ( n = 50 ) 
Nakagawa71 T1 
T2 
25 % ( n = 151 ) 
41 % ( n = 322 ) 
Anthony Yuen 60 T1 / T2 30.5 % ( n = 35 ) 
Al-rajhi 72 T1 / T2 34 % ( n = 85 ) 
Kligerman34 T1 / T2 42 % 
Vermund73 T1 
T2 
45 % 
49 % 
Vandenbrouck 59 T1 / T2 53 % ( n = 39 ) 
Present T1 
T2 
38.3 % ( n = 134 ) 
61.7 % ( n = 102 ) 
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 The rates of occult metastases when compared to other 
series are found to be lower in our series. The number of 
clinically identified recurrences are 41 % and 71.5 % for T1 & 
T2 lesions for patients offered observation. However, if 
pathologically negative but clinically palpable nodes are 
excluded from analysis, the rates of actual neck failure for T1 & 
T2 lesions are 38.3 % & 61. 7 %.The rates of recurrences are 
found comparable for T1 lesions but are much higher for T2 
lesions as compared to other series. 
 
 The incidence of occult metastases may represent a lower 
value partly due to the pathologic techniques used for analysis. 
If the nodes are submitted as bisected specimen, then small foci 
of metastases tend to be missed50. This tends to underestimate 
the actual incidence of micrometastases. 
 
 Civantos et al50 report that even with 3 to 6 mm cuts on 
routine H & E staining, using IHC in addition to conventional 
stains show higher incidence of metastatic foci in the lymph 
nodes. 
 
 Hence, it may have been the case that if further nodal 
clearance and IHC studies are performed on the specimen, the 
rates of finding occult metastases may be higher.  
 
 The incidence of contralateral metastases was 4.5 % in 
our study, comparable to the reported rates of 4% to 6 %64,65. 
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PREDICTIVE FACTORS FOR NODAL METASTASES 
 
 On multivariate analysis, the factors found to be 
significantly associated with increased risk of neck nodal 
metastases were the growth pattern of the primary tumor and T 
stage of the primary. 
 
 T1 lesions have a lesser incidence of nodal metastases and 
an infiltrating pattern of growth of the primary has a higher 
incidence of nodal metastases. This association has already 
been reported previously by many authors25,31,32.  
 
 Most lesions in our study were treated by brachytherapy. 
Hence the other significant factors reported in various surgical 
series like depth of infiltration, muscular involvement, presence 
of desmoplastic stroma and type of infiltration could not be 
studied. 
 
 As it is known that local control rates are similar with 
either surgery or brachytherapy for early stage lesions, the 
treatment of primary should not be a factor in predicting the 
incidence of nodal metastases. This was found to be the case in 
our study, which revealed no association between treatment of 
primary and incidence of nodal metastases. 
 
 Grade of the tumor, age and gender were also not found to 
influence the incidence of nodal metastases in our series in 
contrast to other series23,30,74. 
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TREATMENT RESULTS 
 
 The 5 year disease free & overall survival for the 
treatment groups are as follows. 
 GROUP 
P – VALUE 
Overall survival 
Observation :   64 % 
Elective neck dissection :   86% 
Elective neck radiation :   69% 
 
 
< 0.01* 
0.21* 
Disease free survival 
Observation  :   62 % 
Elective neck dissection :   77% 
Elective neck radiation  :   70 % 
 
< 0.02* 
 
0.1* 
 ( * Significance compared with the observation group ) 
 
 As a group, the elective neck treatment group did not have 
a significant advantage ( p=0.6 ), but the elective neck 
dissection group had a statistically significant disease free & 
overall survival advantage over the other two groups in our 
series.  
 Vandenbrouck et al59 and Anthony Yuen60 however found 
no survival advantage of elective neck dissection as compared 
to observation and delayed intervention. The reported survivals 
in various series are as follows 
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SERIES ELECTIVE NECK DISSECTION ( 5 yr ) 
OBSERVATION
( 5 yr ) 
Anthony 
Yuen60 89 % 87 % 
Haddadin62 80.5 % 44.8 % 
D’ Cruz63 60 % 60 % 
Current Study 86 % 64 % 
C.J.O’Brien66 
( 3 year survival ) 89 % 90 % 
Kligerman34 
( 3 year survival ) 72 % 49 % 
 
The disease free survival as reported from other series are : 
SERIES ELECTIVE NECK 
DISSECTION 
OBSERVATION 
D’Cruz63 68% 74% 
Current 
Study 
77% 62% 
Fakih38 
( 20 months ) 
63 % 52 % 
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 The differences in survival could be explained by 
presence of adverse pathologic findings seen in patients 
undergoing delayed neck dissection. In the observation group, 
there was 31.9 % multinodal involvement and 54.9 % incidence 
of perinodal disease in patients undergoing delayed neck 
dissection. This contrasts against 20.3 % pathologic 
involvement, 7.3 % multinodal involvement and 12.5 % 
perinodal spread in patients undergoing elective neck 
dissection. 
 
 As all these are predictors of high recurrence rates and 
poor survival, this may contribute to the detriment in survival 
noted in this group of patients. The incidence of perinodal 
spread in elective neck dissection specimens as reported by 
other series are 13 %68, 17% by Myers et al58 and 19%59. The 
highest reported was from a series of 337 patients from 
Gourin75, citing rates of 43% but many T3/T4 patients were 
also included in that study.  
 
 Multiple node positivity has been reported in 13%58 
to19%60 of elective neck dissection specimens and is a factor 
affecting neck recurrences. Our rate was found to be lower than 
in other series.   
58 
 
 Incidence of perinodal spread in clinically palpable nodes 
are much higher and reported rates from various series are from 
43%75 to 60%76. The negative impact of perinodal spread on 
neck and distant recurrences has already been discussed58,59. 
We had comparable rates of perinodal spread in the delayed 
neck dissection group. 
 
 As elective neck dissection is aimed at addressing the 
micrometastases at an early stage, it would be intuitive that the 
survival advantage conferred would be due to better control of 
neck disease at an early stage.   
 
 Another significant finding in our study is the higher neck 
salvagability rates among the observed neck group noted in our 
series – 76.5 %. Although Yuen60 reports a successful 
salvagability rate of 100 %, other series have been unable to 
report such high rates. Much lower rates have been generally 
reported previously – 37.5 % to 62 %77,78. 
 
 When considering salvage rates in our series it must be 
seen that almost 93 % of all neck recurrences were technically 
amenable to salvage, however actual salvage rates were lower 
because of patients declining further treatment. This accounted 
for 16.5 % of all neck recurrences and this could potentially 
reduce the survival rates. 
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 The argument that waiting for neck nodes to appear 
clinically may result in unsalvagability does not seem to be a 
major problem in our study; for us the greater problem was the 
patient declining further treatment.  
 
 The survival rates of patients who had radiation to the 
neck were not significantly different from patients whose necks 
were observed. This may have been because patients whose 
tumors were large and not suitable for brachytherapy were 
offered only external radiation. Also the radiation portals 
included only the upper neck and the lower neck was not 
routinely addressed. Also the relatively few patients in our 
study may have accounted for some of the differences. 
 
 Thus from the discussion of our findings, it may be seen 
that elective neck dissection confers benefit for patients with 
N0 neck and though survival is better in this group, other 
factors like adverse pathologic features on neck dissection 
specimen and patient declining treatment may have led to 
poorer outcomes in the observation group.  
 
 A few significant factors seem to emerge from our 
analysis. The incidence of occult metastases is in the order of 
20 % which is generally considered as an indication for elective 
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treatment and hence all T1 & T2 carcinomas of oral tongue 
merit elective treatment. The factors found to have significant 
influence of nodal metastases include the T stage and 
infiltrating pattern of growth. 
 
 The relative merits of elective neck dissection and 
observation are still contested though a benefit was conferred 
by elective dissection in our study. The greatest drawbacks seen 
in the observation arm were the higher incidence of clinically 
detected neck metastases and the significantly large proportion 
of patients refusing treatment for the same. 
 
 As most of the models predicting occult nodal metastases 
are described with reference to surgically treated primaries, 
there is paucity of such criteria for lesions treated by radiation 
as is the case in our institute.  
 
 With our current understanding of genetic models and 
other advances in molecular biology, our efforts should aim to 
develop predictive models for neck nodal metastases which can 
help us in choosing patients for elective neck treatment thus 
sparing the majority of other patients the morbidity of such 
treatment.  
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CONCLUSIONS 
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• The incidence of occult ipsilateral neck nodal metastases 
is around 20 % in T1 & T2 tongue carcinomas 
• The rates of ipsilateral neck nodal recurrences are much 
higher (45 %) in patients whose necks are observed.  
• The incidence of contralateral neck metastases is in the 
order of 5 % across all treatment groups. 
• Higher T stage and an infiltrating pattern of growth of the 
primary were the only significant predictive factors of higher 
incidence of neck metastases among the factors analyzed. 
• There was no survival advantage for the elective neck 
treatment group compared to the observation group. However 
patients undergoing elective neck dissection had a significantly 
better disease free and overall survival advantage compared to 
the observation group. 
• Neck salvagability rate for the observation group was 
76.5% in our series, though 16.5 % of all potentially 
salvageable patients refused treatment. 
• Elective neck dissection is to be considered for treatment 
of all N0 necks in early tongue carcinomas. 
• Better models predicting occult metastases are required to 
identify patients with higher incidence of neck node metastases 
and further randomized prospective studies comparing the 
treatment options are also the need of the hour.  
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